Literature DB >> 27146427

Central fatigue in multiple sclerosis: a review of the literature.

Pamela Newland1, Angela Starkweather2, Matthew Sorenson3,4.   

Abstract

CONCEPT: Fatigue is a major concern for patients with multiple sclerosis (MS). A clear definition of MS-related fatigue is a prerequisite for appropriate instruments for fatigue assessment. In turn, accurate assessment of fatigue in MS will enhance exploration of plausible mechanisms underlying this common and distressing symptom. Content/
Objectives: To provide an integrative review of the current literature on theoretical models used to study fatigue in MS, instruments used to assess fatigue and other factors that impact fatigue during the various phases of MS. DATA SOURCES: PUBMED, OVID, Ovid Health Star, Ovid MEDINE, CINAHL, Health and Psychosocial Instruments (HaPI), and PsycINFO. Seventeen articles fit the inclusion criteria and were included in the review.
RESULTS: Definitions of MS-related fatigue are reviewed. Several studies found a link with neurotransmitter dysfunction, circadian rhythm, and the timing of fatigue. Central fatigue in MS is associated with neurotransmitters disruptions as well as circadian rhythm disorders, but the evidence is not strong. Perceptions of fatigue or fatigability may arise as either a primary or secondary manifestation of disease. Based on findings from the literature review, a theoretical model of fatigue in MS is proposed.
CONCLUSION: Future research on MS-related fatigue may consider a longitudinal design with a carefully selected self-report instrument to advance understanding of the underlying pathological mechanisms.

Entities:  

Keywords:  Central fatigue; Demyelination; Electroencephalogram; Multiple sclerosis

Mesh:

Year:  2016        PMID: 27146427      PMCID: PMC5102292          DOI: 10.1080/10790268.2016.1168587

Source DB:  PubMed          Journal:  J Spinal Cord Med        ISSN: 1079-0268            Impact factor:   1.985


  60 in total

1.  Validation of the NARCOMS registry: fatigue assessment.

Authors:  Ruth Ann Marrie; Gary Cutter; Tuula Tyry; Olympia Hadjimichael; Denise Campagnolo; Timothy Vollmer
Journal:  Mult Scler       Date:  2005-10       Impact factor: 6.312

Review 2.  Multiple sclerosis-associated fatigue.

Authors:  Lauren B Krupp; Dana J Serafin; Christopher Christodoulou
Journal:  Expert Rev Neurother       Date:  2010-09       Impact factor: 4.618

3.  Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis.

Authors:  Lena Melamud; Daniel Golan; Rafael Luboshitzky; Idit Lavi; Ariel Miller
Journal:  J Neurol Sci       Date:  2011-12-01       Impact factor: 3.181

4.  The relationship between subjective fatigue and cognitive fatigue in advanced multiple sclerosis.

Authors:  A Bailey; S Channon; J G Beaumont
Journal:  Mult Scler       Date:  2007-01       Impact factor: 6.312

Review 5.  Physiopathology of fatigue in multiple sclerosis.

Authors:  Letizia Leocani; Bruno Colombo; Giancarlo Comi
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

6.  Impact of sleep disorder treatment on fatigue in multiple sclerosis.

Authors:  I Côté; D A Trojan; M Kaminska; M Cardoso; A Benedetti; D Weiss; A Robinson; A Bar-Or; Y Lapierre; R J Kimoff
Journal:  Mult Scler       Date:  2012-08-22       Impact factor: 6.312

7.  HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter.

Authors:  Jeroen Melief; Stella J de Wit; Corbert G van Eden; Charlotte Teunissen; Jörg Hamann; Bernard M Uitdehaag; Dick Swaab; Inge Huitinga
Journal:  Acta Neuropathol       Date:  2013-06-28       Impact factor: 17.088

8.  Multiple sclerosis.

Authors:  Alastair Compston; Alasdair Coles
Journal:  Lancet       Date:  2008-10-25       Impact factor: 79.321

9.  Does fatigue occur in MS patients without disability?

Authors:  Helcio Alvarenga-Filho; Regina Maria Papais-Alvarenga; Sonia Regina Carvalho; Heleine Norman Clemente; Claudia Cristina Vasconcelos; Ricardo Marques Dias
Journal:  Int J Neurosci       Date:  2014-05-19       Impact factor: 2.292

10.  Fatigue is associated with poor sleep in people with multiple sclerosis and cognitive impairment.

Authors:  Michelle H Cameron; Vanessa Peterson; Eilis A Boudreau; Ashley Downs; Jesus Lovera; Edward Kim; Garnett P McMillan; Aaron P Turner; Jodie K Haselkorn; Dennis Bourdette
Journal:  Mult Scler Int       Date:  2014-03-05
View more
  12 in total

1.  Effects of low-dose naltrexone on quality of life in high-grade glioma patients: a placebo-controlled, double-blind randomized trial.

Authors:  Katherine B Peters; Mary L Affronti; Sarah Woodring; Eric Lipp; Patrick Healy; James E Herndon; Elizabeth S Miller; Maria W Freeman; Dina M Randazzo; Annick Desjardins; Henry S Friedman
Journal:  Support Care Cancer       Date:  2022-01-10       Impact factor: 3.603

2.  FutureMS cohort profile: a Scottish multicentre inception cohort study of relapsing-remitting multiple sclerosis.

Authors:  Patrick K A Kearns; Sarah J Martin; Jessie Chang; Rozanna Meijboom; Elizabeth N York; Yingdi Chen; Christine Weaver; Amy Stenson; Katarzyna Hafezi; Stacey Thomson; Elizabeth Freyer; Lee Murphy; Adil Harroud; Peter Foley; David Hunt; Margaret McLeod; Jonathon O'Riordan; F J Carod-Artal; Niall J J MacDougall; Sergio E Baranzini; Adam D Waldman; Peter Connick; Siddharthan Chandran
Journal:  BMJ Open       Date:  2022-06-29       Impact factor: 3.006

3.  Fatigue is associated with worse cognitive and everyday functioning in older persons with HIV.

Authors:  Laura M Campbell; Ni Sun-Suslow; Anne Heaton; Robert K Heaton; Ronald J Ellis; David J Moore; Raeanne C Moore
Journal:  AIDS       Date:  2022-01-06       Impact factor: 4.632

4.  Exploring the patient perspective of fatigue in adults with visual impairment: a qualitative study.

Authors:  Wouter Schakel; Christina Bode; Hilde P A van der Aa; Carel T J Hulshof; Judith E Bosmans; Gerardus H M B van Rens; Ruth M A van Nispen
Journal:  BMJ Open       Date:  2017-08-03       Impact factor: 2.692

Review 5.  Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Int J Mol Sci       Date:  2018-04-16       Impact factor: 5.923

6.  Neurofilament light chain serum levels correlate with 10-year MRI outcomes in multiple sclerosis.

Authors:  Tanuja Chitnis; Cindy Gonzalez; Brian C Healy; Shrishti Saxena; Mattia Rosso; Christian Barro; Zuzanna Michalak; Anu Paul; Pia Kivisakk; Camilo Diaz-Cruz; Neda Sattarnezhad; Isabelle V Pierre; Bonnie I Glanz; Davorka Tomic; Harald Kropshofer; Dieter Häring; David Leppert; Ludwig Kappos; Rohit Bakshi; Howard L Weiner; Jens Kuhle
Journal:  Ann Clin Transl Neurol       Date:  2018-10-16       Impact factor: 4.511

7.  The Effect of Fatigue and Pain Self- Efficacy on Health-Related Quality of Life Among Patients with Multiple Sclerosis.

Authors:  Fevronia Adamopoulou; Victoria Alikari; Sofia Zyga; Maria Tsironi; Fotini Tzavella; Natalia Giannakopoulou; Paraskevi Theofilou
Journal:  Mater Sociomed       Date:  2019-03

8.  Sleep architecture, obstructive sleep apnea and functional outcomes in adults with a history of Tick-borne encephalitis.

Authors:  Malin Veje; Marie Studahl; Erik Thunström; Erika Stentoft; Peter Nolskog; Yeliz Celik; Yüksel Peker
Journal:  PLoS One       Date:  2021-02-08       Impact factor: 3.240

9.  Effectiveness of massage therapy on fatigue and pain in patients with multiple sclerosis: A systematic review and meta-analysis.

Authors:  Shahin Salarvand; Mohammad Eghbal Heidari; Kazem Farahi; Erfan Teymuri; Mohammad Almasian; Saeid Bitaraf
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-06-14

10.  Reduction in Fatigue Symptoms Following the Administration of Nutritional Supplements in Patients with Multiple Sclerosis.

Authors:  Pasquale Ferorelli; Francesco Antonelli; Anna Shevchenko; Carlo Mischiati; Manfred Doepp; Stefano Lenzi; Ilaria Borromeo; Giordana Feriotto; Simone Beninati
Journal:  Med Sci (Basel)       Date:  2021-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.